Correction: Interleukin-1 receptor antagonist overexpression in mesenchymal stem cells improves hemorrhagic cystitis outcomes via HtrA serine peptidase 3.

IF 7.1 2区医学 Q1 CELL & TISSUE ENGINEERING

Stem Cell Research & Therapy Pub Date : 2025-07-07 DOI:10.1186/s13287-025-04494-0

Jialin Song, Yanxiao Han, Yuyan Chen, Lin Cheng, Juan Xiao, Ai Li, Dexiao Kong, Yang Jiang, Chengyun Zheng

引用次数: 0

查看原文本刊更多论文

更正：白细胞介素-1受体拮抗剂在间充质干细胞中的过度表达通过HtrA丝氨酸肽酶3改善出血性膀胱炎的预后。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Stem Cell Research & Therapy CELL BIOLOGY-MEDICINE, RESEARCH & EXPERIMENTAL

CiteScore

13.20

自引率

8.00%

发文量

525

审稿时长

1 months

期刊介绍： Stem Cell Research & Therapy serves as a leading platform for translational research in stem cell therapies. This international, peer-reviewed journal publishes high-quality open-access research articles, with a focus on basic, translational, and clinical research in stem cell therapeutics and regenerative therapies. Coverage includes animal models and clinical trials. Additionally, the journal offers reviews, viewpoints, commentaries, and reports.